Dr. Reddy's Laboratories is targeting to triple its reach to 1.5 billion patients by 2030 as part of its sustainability goals. Under its sustainability goals for the next decade, it is making its products accessible and affordable for patients and 25 per cent of new launches to be first to market by 2027.
Besides, by 2030 the company will use 100 per cent renewable power and it will also be carbon-neutral in direct emissions, while it is targeting 12.5 per cent reduction in indirect carbon emissions.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
